中国脑瘤发病和死亡流行现况及预测OACSTPCD
The epidemiology and prediction of brain tumors incidence and mortality in China
目的 描述 2020 年中国脑瘤发病和死亡的流行现况,预测到 2040 年中国脑瘤发病和死亡负担,为更科学的制定我国脑瘤防治策略提供数据支持.方法 提取国际癌症研究署(IARC)2020 年 Cancer Today数据库.采用Segi's世界标准人口的年龄构成计算脑瘤的年龄标化发病率和死亡率.分性别、年龄别描述中国脑瘤发病和死亡情况.利用《世界人口展望(2022)》数据结合脑瘤发病和死亡率预测到 2040 年中国脑瘤发病和死亡负担.结果 2020 年中国脑瘤新发病例约 8.0 万人,死亡约 6.5 万人,年龄标化发病率和死亡率分别为 4.1/10 万和 3.2/10 万.中国脑瘤的年龄标化发病率低于美国、绝大部分欧洲、北美洲等地区脑瘤发病率,但高于非洲、中美洲、加勒比海等地区.2040 年中国脑瘤的发病和死亡人数相比 2020 年分别增长 32.1%和 41.5%.结论 中国脑瘤负担整体比较严重,需进一步明确人群脑瘤危险因素,有针对性地完善相应防控策略以降低脑瘤负担.
Objective To describe the incidence and mortality of brain tumors in China in 2020 and to predict the disease burden up to 2040.Methods The brain tumor incidence and mortality in 2020 were recorded based on the data from International Agency for Cancer Research(IARC),Cancer Today database.The incidence and mortality were standardized by age using Segi's world standard population.The burden of brain tumors in 2040 was predicted with assuming that national rates remained constant in 2020.Results It was estimated there were approximately 79 600 new brain tumors cases and 65 200 deaths in China in 2020.The age-standardized incidence and mortality rates of brain tumors in China were 4.1/100 000 and 3.2/100 000,respectively,which were lower than the United States of America,most of European countries and Australia.The incidence and mortality were higher than Africa,central America,and the Caribbean.From 2020 to 2040,the brain tumors cases and deaths are predicted to have an increase as 32.1%and 41.5%respectively.Conclusions The disease burden of brain tumors was still heavy in China.Further studies are urgently needed to clarify the epidemic trend of tissue typing and risk factors of brain tumors,which may support the development of effective prevention strategies.
雷少元;李玉龙;孙菲;刘宏军;吴月;郭艳苏
首都医科大学 宣武医院 循证医学中心,北京 100053中共中央办公厅 警卫局 保健处,北京 100034首都医科大学宣武医院老年保健及疾病防治中心办公室,北京 100053首都医科大学 宣武医院 循证医学中心,北京 100053||首都医科大学宣武医院老年保健及疾病防治中心办公室,北京 100053||北京市老年病医疗研究中心,北京 100053
临床医学
脑瘤发病率死亡率中国
brain tumorsincidencemortalityChina
《基础医学与临床》 2024 (004)
ET-1介导的Jagged1/Notch1通路激活在肌萎缩侧索硬化中的作用和机制研究
454-458 / 5
国家自然科学基金(81971200);北京市自然科学基金(7222082);北京市老年病医疗研究中心改革与发展项目(11000023T000002036320)
评论